Davita - Moore Dialysis in Moore, Oklahoma - Dialysis Center

Davita - Moore Dialysis is a medicare approved dialysis facility center in Moore, Oklahoma and it has 12 dialysis stations. It is located in Cleveland county at 620 S. Santa Fe Ave, Moore, OK, 73160. You can reach out to the office of Davita - Moore Dialysis at (405) 799-2439. This dialysis clinic is managed and/or owned by Davita. Davita - Moore Dialysis has the following ownership type - Profit. It was first certified by medicare in August, 2016. The medicare id for this facility is 372603 and it accepts patients under medicare ESRD program.

Name	Davita - Moore Dialysis
Location	620 S. Santa Fe Ave, Moore, Oklahoma
No. of Dialysis Stations	12
Medicare ID	372603
Managed By	Davita
Ownership Type	Profit
Late Shifts	No

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Davita - Moore Dialysis from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number	1821496217
Organization Name	Moore Dialysis
Doing Business As	Stockton Dialysis Llc
Address	620 S Santa Fe Ave Ste C Moore, Oklahoma, 73160
Phone Number	(405) 799-2439

Dialysis patients with Hemoglobin data	17
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL	6

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

• Hemodialysis

  Adult patients getting regular hemodialysis at the center	31
  Adult patient months included in Kt/V greater than or equal to 1.2	242
  Percentage of adult patients getting regular hemodialysis at the center	99
  Percentage of pediatric patients getting regular hemodialysis at the center

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Davita - Moore Dialysis with elevated calcium levels.

Patients with hypercalcemia	31
Hypercalcemia patient months	242
Hypercalcemia patients with serumcalcium greater than 10.2 mg	1
Patients with Serumphosphor	33
Patients with Serumphosphor less than 3.5 mg/dL	14
Patients with Serumphosphor from 3.5 to 4.5 mg/dL	26
Patients with Serumphosphor from 4.6 to 5.5 mg/dL	36
Patients with Serumphosphor from 5.6 to 7 mg/dL	14
Patients with Serumphosphor greater than 7 mg/dL	9

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries	36
Patient months included in arterial venous fistula and catheter summaries	188
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment	81
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer	13

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) Year	January, 2016 - December, 2016
Patients in facility's Hospitalization Summary	8
Hospitalization Rate in facility	(Not Available)
Hospitalization Rate: Upper Confidence Limit
Hospitalization Rate: Lower Confidence Limit